Clinical Trials on Acquired Immunodeficiency Syndrome
Total 34765 results
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineShionogiCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
Glaxo WellcomeCompletedHIV InfectionsUnited States, Puerto Rico, Australia
-
Merck Sharp & Dohme LLCNot yet recruitingHIV | Human Immunodeficiency Virus
-
Hospices Civils de LyonTerminatedSelection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses (FXR#2)Human Immunodeficiency Virus I InfectionFrance
-
AbbVieCompletedHIV Infection | HIV-1 | Human Immunodeficiency Virus (HIV)United States, Australia, Canada, Puerto Rico
-
National Taipei University of Nursing and Health...CompletedHuman Immunodeficiency VirusIndonesia
-
Fred Hutchinson Cancer CenterUniversity of WashingtonCompleted
-
Auritec PharmaceuticalsEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHuman Immunodeficiency Virus (HIV) ProphylaxisUnited States
-
Unity Health TorontoCompletedHIV | Human Immunodeficiency VirusCanada
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Germany, Italy, Russian Federation
-
University of PennsylvaniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSexually Transmitted Diseases | Human Immunodeficiency Virus Infection
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, Canada, Italy, Belgium, Romania
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited Kingdom
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
AbbVie (prior sponsor, Abbott)CompletedDrug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infectionHuman Immunodeficiency Virus InfectionJapan
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedFeasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected WomenHuman Immunodeficiency Virus (HIV) | Self-esteem | Self-efficacyUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, Puerto Rico
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus I
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompleted
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | Infection, Human Immunodeficiency VirusUnited States
-
bioLytical LaboratoriesNot yet recruitingHuman Immunodeficiency Virus I Infection | Human Immunodeficiency Virus II Infection
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHuman Immunodeficiency Virus | Immune Reconstitution Inflammatory SyndromeKenya
-
University of TartuState University of New York - Downstate Medical Center; Tibotec Pharmaceutical...CompletedAcquired Immunodeficiency Syndrome | Medication Adherence | Acute HIV InfectionEstonia
-
University of California, San FranciscoBausch Health Americas, Inc.; California HIV/AIDS Research ProgramCompletedHIV Infections | Acquired Immunodeficiency Syndrome | Sexually Transmitted Diseases | Lentivirus Infections | Immune System DiseasesUnited States
-
National Taiwan University HospitalCompleted
-
Medical College of WisconsinEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingAcquired Immunodeficiency Syndrome | HIVBulgaria
-
National Institute of Allergy and Infectious Diseases...PfizerCompletedHIV Infections | HistoplasmosisUnited States
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedAcquired Immunodeficiency Syndrome | HIV Seropositivity | Pregnancy, High Risk